October 2017 | AIChE

You are here

October 2017

Scott McIvor

The general research interest of Dr. McIvor's laboratory is genetic therapy for inherited diseases and cancer. Specific research activities include: (i) Use of recombinant lentiviral vectors for gene transfer into hematopoietic stem cells in the treatment of cancer and inherited disorders such as immunodeficiency diseases and lysosomal storage diseases; (ii) Introduction of drug-resistance genes into normal hematopoietic cells to protect against the toxic side effects of cancer chemotherapy; (iii) Use of adeno-associated virus for treatment of storage diseases and as a vector...Read more

Kannan Rangaramanujam

Dr. Kannan Rangaramanujam is the Arnall Patz distinguished professor of ophthalmology and co-director of center for nanomedicine at the Wilmer Eye Institute at Johns Hopkins School of Medicine. He has joint/courtesy appointments in Chemical and Biomolecular Engineering, and Materials Science and Engineering at Johns Hopkins. He is also a research scientist at the Kennedy-Krieger Institute. He obtained his PhD in Chemical Engineering from the California Institute of Technology, and followed it with a post-doc from the University of Minnesota. His research interested are in...Read more

Juergen Hahn

Juergen Hahn is the department head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute in addition to holding an appointment in the Department of Chemical & Biological Engineering. He received his Diploma degree in engineering from RWTH Aachen, Germany, in 1997, and his MS and Ph.D. degrees in chemical engineering from the University of Texas, Austin, in 1998 and 2002, respectively. He was a post-doctoral researcher at the Chair for Process Systems Engineering at RWTH Aachen, Germany, before joining the Department of Chemical Engineering at Texas A&M...Read more

Michael C. McAlpine

Michael C. McAlpine is the Benjamin Mayhugh Associate Professor of Mechanical Engineering at the University of Minnesota. Previously, he was an Assistant Professor of Mechanical and Aerospace Engineering at Princeton University (2008-2015). He received a B.S. in Chemistry with honors from Brown University (2000) and a Ph.D. in Chemistry from Harvard University (2006). His research is focused on 3D printing functional materials & devices, including the three-dimensional interweaving of biological and electronic materials using 3D printing. He has received a number of awards, including...Read more

Michael Look

Michael Look is Ph.D.-level scientist specializing in immunology and drug development . He has Industrial research experience in early-stage preclinical programs and a proven record of publication in journals such as: JCI, Nature Materials, Advanced Drug Delivery Reviews, and Biomaterials. Michael Look also has expertise in: immunology, autoimmunity, nanotechnology, drug delivery systems, analytical methods, assay development, immunoengineering, microfluidics, and point-of-care diagnosticsRead more

Stelios T. Andreadis

Stelios T. Andreadis received his M.S. (Applied Mathematics) and Ph.D. degree in Chemical Engineering from the University of Michigan studying the dynamics of retroviral gene transfer for gene therapy. He then pursued postdoctoral training at the Center for Engineering in Medicine at Harvard Medical School, where he worked in the areas of gene therapy, tissue engineering and regenerative medicine. Currently he serves as Professor and Chair of Chemical and Biological Engineering, Professor of Biomedical Engineering and Member of the Center of Excellence in Bioinformatics and Life Sciences...Read more

John Santini

Dr. Santini is a startup company executive, serial entrepreneur, inventor, and scientist that has spent his career focused on the creation and growth of businesses developing next-generation pharmaceuticals, drug delivery systems, biosensors, and mobile health products. Prior his current roles as CEO of Vergent Bioscience and Board Member/co-founder of Univ. of Minnesota biotech spinout ApoGen Biotechnologies, he served as the CEO or CTO of four healthcare startups – MicroCHIPS, On Demand Therapeutics, RadioRx, and IRISense – developing products such as novel cancer...Read more

Pages